Newswise — The American Society for Clinical Pharmacology & Therapeutics (ASCPT) unveiled on March 9 a new visual brand identity and logo during its 2016 Annual Meeting in San Diego, California. The new logo and brand identity were launched to help support ASCPT’s recently released 2015-2020 Strategic Plan.
ASCPT is an international not-for-profit association that represents more than 2,200 professionals, whose primary interest is to advance the science and practice of Clinical Pharmacology and Translational Medicine for the therapeutic benefit of patients and society. ASCPT is the largest scientific and professional organization serving the disciplines of Clinical Pharmacology and Translational Medicine.
ASCPT’s new logo is part of a strategic rebranding effort that began in late 2015 and is designed to better align the association with the needs of its members and a changing professional environment.
ASCPT President Mario L. Rocci, Jr., PhD, said the new logo has been modernized to better convey the spirit, mission and scope of the organization, which has recently placed a stronger emphasis on leadership and programming in Translational Medicine.
“With the adoption of a new strategic plan in 2015, ASCPT is entering an exciting new era of growth and development. The new logo and brand identity support these new strategic directions,” he said. “We believe the advance of Translational Medicine should be a priority in health care, and Clinical Pharmacology and Therapeutics can play a pivotal role in helping it achieve its potential on behalf of patients.”
ASCPT defines Translational Medicine in its 2015-2020 Strategic Plan as “the process of turning observations in the laboratory, clinic and community into interventions that improve the health of individuals and the public – from diagnostics and therapeutics to medical procedures and behavioral changes.” A more detailed discussion of ASCPT’s focus on Translational Medicine is available at the ASCPT website, www.ascpt.org.
ASCPT’s new logo utilizes a new typeface and the use of an abstract illustration that symbolizes the organization’s role in fostering and encouraging innovation and the discovery of new compounds that can lead to the development of new medicine. Expanding concentric circles in the logo suggest the growth and impact of scientific discovery – which ultimately benefits patients and improves lives.
In addition, ASCPT has changed its primary corporate colors from green and orange to blue and white.
ASCPT conducted environmental research and an assessment of stakeholder attitudes and opinions about the brand to determine the need for a brand update, and design and communications consultants helped guide the process of redesigning the logo and updating the overall visual identity.
As a part of ASCPT’s new brand identity, its various communications channels will be updated over the coming year. Late in 2016 an ASCPT website redesign project will be launched.
Complementing its visual brand update, ASCPT said it will also utilize the phrase “today’s discovery, tomorrow’s medicine” to help sum up its strategic mission.
“Discovery and the development of effective medicine is what our discipline is fundamentally engaged in,” Dr.Rocci said. “Our new strategic emphasis is the goal of moving today’s discoveries much more efficiently toward ultimately benefiting patients.”
For additional details about ASCPT’s new brand identity, and to view the new logo, please visit www.ascpt.org.
For more information, please call 703-836-6981.
About ASCPT: The American Society for Clinical Pharmacology & Therapeutics (ASCPT) was founded in 1900, and consists of over 2,200 professionals whose primary interest is to advance the science and practice of clinical pharmacology and translational medicine for the therapeutic benefit of patients and society. ASCPT is the largest scientific and professional organization serving the disciplines of Clinical Pharmacology and Translational Medicine. ASCPT focuses on improving the understanding and use of existing drug therapies and developing safer and more effective treatments for the future. Our memberships' unique combination of scientific and clinical expertise makes them especially qualified to understand the impact of disease on patients, the compelling need for effective drug therapy, and the efforts necessary to meet those needs. Such efforts include research, exchange of scientific information, and awareness-building of issues that affect drug development and regulation.
RSS